Chronic Kidney Disease. Chronic kidney disease, stage 5
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age over and equal to 18 years Written informed consent to participate in the study Diagnosis of chronic kidney failure and receiving maintenance hemodialysis for at least 3 months Undergoing at least 3 hemodialysis sessions per week No hospitalization within the past month No diagnosed psychiatric or cognitive disorders Having the physical ability to perform exercise on a stationary bicycle during dialysis
Exclusion criteria
Exclusion criteria: Age less than 18 years Lack of written informed consent to participate in the study Not having chronic kidney disease and receiving hemodialysis for less than three months Having fewer than three hemodialysis sessions per week Hospitalization within the past month Have a diagnosed psychiatric or cognitive disorder Not being physically fit enough to exercise on a stationary bike during dialysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dialysis adequacy (Kt/V). Timepoint: Dialysis adequacy (Kt/V) is measured at three time points: baseline, week 4 (mid-study), and week 8 (end of study). Method of measurement: Dialysis adequacy (Kt/V) is calculated by collecting blood samples before and after dialysis and entering the laboratory results and dialysis parameters into the corresponding formula.;Laboratory parameters (hemoglobin, creatinine, etc.). Timepoint: Laboratory parameters is measured at three time points: baseline, week 4 (mid-study), and week 8 (end of study). Method of measurement: Laboratory parameters are collected according to standard procedures at the beginning of the dialysis session before starting dialysis from a fasting patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic parameters (systolic and diastolic blood pressure, pulse, and oxygen saturation). Timepoint: Hemodynamic parameters, including blood pressure, pulse, and oxygen saturation, are monitored at three time points: the beginning of the study, mid-study (week four), and the end of the study (week eight), both before and after dialysis. Method of measurement: Hemodynamic parameters are monitored at the patient’s bedside using calibrated blood pressure monitors and pulse oximeters. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences